Mitochondrial Mutation Linked to Immune Dysfunction, Offering New Hope for Treatment
Table of Contents
A groundbreaking new study reveals how a specific mitochondrial mutation fundamentally alters immune function, possibly explaining the frequent and severe infections experienced by individuals with inherited primary mitochondrial disorders. Published this week in Nature Communications, the research offers a crucial step towards understanding these complex conditions and identifying potential therapeutic strategies.Patients with these disorders often exhibit increased susceptibility to infections like sepsis. This new work, conducted using a mouse model, illuminates the underlying mechanisms driving this vulnerability, suggesting that these disorders are not simply metabolic diseases, but also disorders of immune regulation.
Unraveling the Connection: Mitochondrial Defects and the Immune System
The research centers on the m.5019A>G mt-tRNAAla mutation, which mimics mutations seen in human patients. Researchers discovered this single inherited mutation triggers a cascade of immune responses, ultimately disrupting the body’s ability to maintain immune homeostasis.
“Many patients living with inherited primary mitochondrial disorders appear to be more susceptible to recurrent infections and sepsis, which can trigger the onset of symptoms, worsen developed symptoms or cause meaningful mortality,” a senior researcher explained. “The precise mechanistic basis for this has been unclear, which of course hampers any attempt to develop effective therapies.”
Specifically, the mutation causes a dramatic shift in the behavior of macrophages, key immune cells responsible for engulfing and destroying pathogens. These mutated macrophages exhibit a unique two-phase response. Initially,they release a surge of interferons – signaling molecules that activate the immune system. This “interferon burst” is followed by a delayed release of mitochondrial DNA and RNA, further fueling the immune response.
While interferons are essential for fighting off viruses and pathogens, the study reveals that this unchecked activation can be detrimental. The release of interferons triggers the production of toxic reactive oxygen species, potentially leading to an overactive immune response and widespread inflammation.
This newly identified dual mechanism, researchers say, represents an “antiviral alarm” that, when constantly triggered by mitochondrial defects, can contribute to chronic inflammation and autoimmune-like symptoms. Mice with the mitochondrial mutation displayed excessive interferon signaling and worsened illness when exposed to a toxin, demonstrating the disruption of immune balance at the whole-body level.
Reframing Mitochondrial Disorders and Potential Therapeutic Targets
The findings have significant implications for how we understand and treat these rare but devastating diseases. According to researchers,demonstrating that a single mtDNA mutation is sufficient to disturb innate immunity may help reframe primary mitochondrial disorders.
“If we could therapeutically restore mitochondrial function or modulate interferon signaling, such approaches could one day be helpful for mitigating inflammation and sepsis risk,” a researcher added.
While acknowledging the research is in its early stages, the team is optimistic about its potential. “Given the rare nature of these disorders, we performed this work in an experimentally tractable mouse model, so we don’t want to overstate the findings,” one researcher cautioned. “However, we have uncovered a number of pieces of the puzzle that supports descriptive reporting in human patients.”
the study, led by dylan Ryan, Assistant Professor in Trinity’s School of Biochemistry and Immunology, and Dr. Eloïse Marques, research associate in the MRC Mitochondrial Biology Unit, marks a pivotal moment in mitochondrial disease research, offering a new avenue for therapeutic intervention and hope for patients and their families.
Source: Marques, E., et al. (2025). An inherited mitochondrial DNA mutation remodels inflammatory cytokine responses in macrophages and in vivo in mice.Nature Communications. doi: 10.1038/s41467-025-65023-4. https://www.nature.com/articles/s41467-025-65023-4.
